Literature DB >> 20594230

Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver.

Elango Kathirvel1, Philip Chen, Kengathevy Morgan, Samuel W French, Timothy R Morgan.   

Abstract

BACKGROUND AND AIM: Reactive oxygen species produced by cytochrome P4502E1 (CYP2E1) are believed to play a role in pathophysiology of non-alcoholic fatty liver disease (NAFLD). However, little is known about the expression, protein content and activity of anti-oxidant enzymes and the role of inducible nitric oxide synthase (iNOS), a source of reactive nitrogen species, in NAFLD. In the present study, we evaluate gene expression, protein content and activity of anti-oxidant enzymes, and iNOS, in a CYP2E1 overexpressing model of non-alcoholic fatty liver (NAFL).
METHODS: Non-transgenic (nTg) and CYP2E1 transgenic (Tg) mice were fed rodent chow for 8 months. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), liver triglycerides, malondialdehyde and protein carbonyls were measured. Gene expression of NF-E2-related factor (Nrf2), superoxide dismutase-1, -2 (SOD-1,2), catalase (CAT), glutathione peroxidase (GPx), heme oxygenase-1 (HO-1) and iNOS were determined. Protein content, activity and nitrosylation of the enzymes were also measured.
RESULTS: Tg mice had greater CYP2E1 activity and histological liver injury. MDA and protein carbonyls were increased, indicating insufficient anti-oxidant response. Gene expression of Nrf2, CAT, GPx, HO-1 and iNOS were significantly increased. Protein content and enzyme activities of most anti-oxidant enzymes were not correspondingly increased. iNOS activity and nitrosylation of CAT and SOD was greater in Tg mice liver.
CONCLUSION: Hepatocyte-specific CYP2E1 overexpression results in increased oxidative stress and nitrosative stress. Several anti-oxidant enzymes are upregulated. Failure of corresponding increase in total protein and activity of anti-oxidant enzymes suggests modification/degradation, possibly by nitrosylation, due to increased iNOS activity in a CYP2E1 overexpressing NAFL mouse model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20594230     DOI: 10.1111/j.1440-1746.2009.06196.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  36 in total

1.  Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance.

Authors:  Haihong Zong; Michal Armoni; Chava Harel; Eddy Karnieli; Jeffrey E Pessin
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-20       Impact factor: 4.310

Review 2.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

3.  Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease.

Authors:  Chun Wang; Jianping Gong; Hao Wu
Journal:  Biomed Rep       Date:  2017-06-14

4.  α7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling.

Authors:  Mohammad Kamrul Hasan; Theodore C Friedman; Carl Sims; Desean L Lee; Jorge Espinoza-Derout; Adaku Ume; Victor Chalfant; Martin L Lee; Indrani Sinha-Hikim; Kabirullah Lutfy; Yanjun Liu; Sushil K Mahata; Amiya P Sinha-Hikim
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

5.  Combined treatment of mulberry leaf and fruit extract ameliorates obesity-related inflammation and oxidative stress in high fat diet-induced obese mice.

Authors:  Hyun Hwa Lim; Soo Jin Yang; Yuri Kim; Myoungsook Lee; Yunsook Lim
Journal:  J Med Food       Date:  2013-08       Impact factor: 2.786

6.  Antioxidant properties of proanthocyanidins attenuate carbon tetrachloride (CCl4)-induced steatosis and liver injury in rats via CYP2E1 regulation.

Authors:  Ning Dai; Yuan Zou; Lei Zhu; Hui-Fang Wang; Mu-Gen Dai
Journal:  J Med Food       Date:  2014-04-08       Impact factor: 2.786

Review 7.  Oxidative stress as a crucial factor in liver diseases.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 8.  Does L-carnitine supplementation affect serum levels of enzymes mainly produced by liver? A systematic review and meta-analysis of randomized controlled clinical trials.

Authors:  Farzaneh Pirmadah; Nahid Ramezani-Jolfaie; Mohammad Mohammadi; Nasir Talenezhad; Cain C T Clark; Amin Salehi-Abargouei
Journal:  Eur J Nutr       Date:  2019-08-05       Impact factor: 5.614

Review 9.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 10.  Autophagy in the liver: cell's cannibalism and beyond.

Authors:  Joseph A Flores-Toro; Kristina L Go; Christiaan Leeuwenburgh; Jae-Sung Kim
Journal:  Arch Pharm Res       Date:  2016-08-11       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.